Pfizer COVID-19 vaccine gets FDA panel recommendation for young kids

The US is one step closer to the anticipated authorization of a COVID-19 vaccine for young kids ages five to 11 years. An independent panel of advisers has recommended the US Food and Drug Administration (FDA) authorize the use of Pfizer’s COVID-19 vaccine in children who fall in this age group, bringing the US closer than ever to a vaccine …